Status: Not yet recruiting
A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.
A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standard of sare versus standard of sare slone in the management of post-mohs micrographic surgery defects.
Participants needed: 160
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: BioLab HoldingsUpdated: Jul 10, 2026
Eligibility criteria
The potential subject must be at least 18 years of age or older. [+8]
The potential subject must agree to attend the weekly study visits required by t... [+8]